CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Biomarker
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
    Technologies and Software
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

U-Medico has been recognized by Life Sciences Review Magazine as the exclusive recipient of “Top 10 Bioanalytical Services Companies in Apac - 2022,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the Life Sciences Review research and editorial team based on insights from an interview with , .

U-Medico
Equipping Labs with Boutique Services

U-Medico

Susumu Uchiyama, Chief Scientific Officer and Dr. Ayano Fukuhara, CEO, U-MedicoSusumu Uchiyama, Chief Scientific Officer and Dr. Ayano Fukuhara, CEO
Beyond vaccine research, the biopharmaceutical line has risen with an influential intensity fueled by R&D improvements, drug development, intensified bioprocesses, and emerging cell and gene therapy. These advancements are complex and come with the need to ensure quality and safety. This necessitates domain expertise and a fully equipped lab such as BSL-2 labs.

Like a cell’s response to a ligand, U-Medico, an analytical and research service provider, is catering to the biopharmaceutical niche for over 15 years with an emphasis on quality through their top-notch analytical services. U-Medico concentrates extensively on biophysical characterization and formulation development.

“Our unique expertise is in techniques like analytical ultracentrifugation (AUC) and hydrogen/ deuterium exchange mass spectrometry (HDX-MS). We discuss with our clients and offer tailor-made solutions and new opportunities by approaching from various perspectives,” says Dr. Ayano Fukuhara, CEO of U-Medico.

U-Medico’s protein aggregates and particles analysis services include AUC service provided in three types of analytical ultracentrifuge systems—XL-I, XL-A, and Optima, one of their latest additions. U-Medico has extensive experience in characterizing complete, empty, and intermediate particles of adeno-associated virus (AAV) vectors. In-depth training and prior experience are essential to carefully handle AUC, and U-Medico’s equally equipped workforce guarantees expert services.

Along with aggregates and particles analysis, U-Medico offers structure analysis for biophysical characterization services that includes HDX-MS, native MS, and of course conventional peptide mapping using mass spectrometry.

The company’s HDX-MS is used in the characterization of biosimilars and antibody drugs, analysis of protein-protein interaction, and rapid epitope determination for biopharmaceuticals. U-Medico’s new HDX-MS system is unique in that it only requires one-tenth the volume of samples than before to better meet client needs.

A thorough understanding of the client’s requirements is critical in U-Medico’s approach to providing services, which is why the company offers expert consulting services, distinguishing them as a research and analytics service provider. When a client approaches U-Medico for a specific service, such as peptide mapping and aggregation assessments required from regulatory agencies or even they don’t know what exactly to do, the company takes a consultative approach and examines the client’s needs throughout the engagement. This allows U-Medico to comprehend what the client requires and offer services accordingly.

Recently, U-Medico extended its services to include cell and gene therapy, recognizing the dramatic growth and demand for analytical skills and techniques in the field. Hosting these services is challenging as they are more sophisticated and complicated than compared to the case of biopharmaceuticals. But with a strong foundation built over years and the guidance of science based and industry experts like Dr. Susumu Uchiyama, U-Medico offers world-class analytical and quality testing services related to gene therapy.

Our unique expertise is in techniques like AUC and HDX-MS. We discuss with our clients and offer these unique solutions and new opportunities

Dr. Uchiyama is a primary player of U-Medico’s core team, who founded and is leading the company in the biopharmaceutical landscape. Dr. Uchiyama is the chief scientific officer at U-Medico and a professor of biotechnology in the graduate school of bioengineering at Osaka University. He is playing a prominent role in the development of cell and gene therapy, leading a major Japanese government project in the field.

Apart from cell and gene therapy, U-Medico recently branched out its services to formulation development. As an extension, it has strategic cooperation with Coriolis Pharma, a leading German company in formulation research and development. This scientific collaboration enables U-Medico to provide complete support for formulation development services.

Through this relationship, the company is also establishing a new door for consumers worldwide to access their top-tier biopharmaceutical services. Based on its collective experience gathered over years of services and research, U-Medico is the provider of choice for offering the highest quality results in the world for each sample they analyze.

Top 10 Bioanalytical Services Companies in Apac - 2022
Current Issue

Company : U-Medico

Management
Susumu Uchiyama, Chief Scientific Officer and Dr. Ayano Fukuhara, CEO

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review . All rights reserved.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/u-medico